Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancing beyond the twists and turns of T cell exhaustion in cancer. | Sci Transl Med | 2022 | 36350991 | PubTator, text mining | PubMed |
| Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. | Sci Transl Med | 2022 | 36350984 | PubTator, text mining | PubMed |
| T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies. | Elife | 2022 | 36350695 | PubTator, text mining | PubMed |
| GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome. | Nat Commun | 2022 | 36347862 | Swiss-Prot, curated | PubMed |
| T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. | Nat Commun | 2022 | 36347843 | PubTator, text mining | PubMed |
| A two-stage hybrid gene selection algorithm combined with machine learning models to predict the rupture status in intracranial aneurysms. | Front Neurosci | 2022 | 36340761 | PubTator, text mining | PubMed |
| Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma. | Front Mol Biosci | 2022 | 36339709 | PubTator, text mining | PubMed |
| Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non-small-cell lung carcinoma. | iScience | 2022 | 36339256 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. | Clin Transl Med | 2022 | 36333281 | PubTator, text mining | PubMed |
| HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control. | Front Immunol | 2022 | 36330531 | PubTator, text mining | PubMed |
| Identification of mRNA expression biomarkers associated with epilepsy and response to valproate with co-expression analysis. | Front Neurol | 2022 | 36330432 | PubTator, text mining | PubMed |
| Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression. | J Immunother Cancer | 2022 | 36323433 | PubTator, text mining | PubMed |
| CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. | BMC Med Genomics | 2022 | 36316684 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications. | Nat Commun | 2022 | 36309526 | PubTator, text mining | PubMed |
| Natural killer cell immunotherapy in glioblastoma. | Discov Oncol | 2022 | 36305981 | PubTator, text mining | PubMed |
| Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. | Clin Transl Med | 2022 | 36305631 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the cell map and transcriptional network of sporadic vestibular schwannoma. | Front Mol Neurosci | 2022 | 36304995 | PubTator, text mining | PubMed |
| Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy. | J Transl Med | 2022 | 36303162 | PubTator, text mining | PubMed |
| Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease. | JCI Insight | 2022 | 36301664 | PubTator, text mining | PubMed |
| Bioinformatics analysis to screen for genes related to myocardial infarction. | Front Genet | 2022 | 36299582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=51